Daisuke Kaya
Nara-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Glucosyl hesperidin benefits in primary biliary cholangitis: a multicenter, open-label, randomized controlled study.
Journal: Clinical and translational gastroenterology
Published: February 24, 2026
Fournier's Gangrene in the Course of Treatment of Advanced Hepatocellular Carcinoma with Molecular-targeted Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: July 24, 2024
Secondary Growth Hormone Deficiency That Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: June 26, 2024
SARS-CoV-2 Vaccination Response in Japanese Patients with Autoimmune Hepatitis: Results of Propensity Score-Matched Case-Control Study.
Journal: Journal of clinical medicine
Published: July 10, 2023
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
Journal: International journal of molecular sciences
Published: September 21, 2021
Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis.
Journal: Medicines (Basel, Switzerland)
Published: July 03, 2021
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
Published: April 08, 2021
The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis.
Journal: Medicine
Published: December 24, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy.
Journal: Journal of clinical medicine
Published: September 28, 2020
Association between ADAMTS13 activity-VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: August 04, 2020
Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
Journal: International journal of molecular sciences
Published: July 23, 2020
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.
Journal: Microorganisms
Published: May 19, 2020
Last Updated: 09/26/2026